RWD is not Insights—PCI Transforms Patient Understanding
RWD alone isn’t enough. To truly understand patients and drive meaningful improvements, you need PCI. Find out why RWD falls short and how PCI bridges the gap, providing pharmaceutical companies with the insights they need.
Q&A with Eiichi Naka: Patient-centricity to Drive Outcomes for Rare Disease
Mr. Eiichi Naka, a senior pharma leader with 40 years experience, discusses patient-centric PSPs and the impact of AI in driving outcomes in rare disease.
Prospection wins APAC Insider 2024 awards!
Prospection has won two prestigious awards from APAC Insider. These achievements reflect our dedication to improving healthcare through cutting-edge technology.
5 Questions with Ipsen’s Nicholas Phillips: AI and Adopting a Patient-centric Intelligence Platform
Discover how AI and patient-centric intelligence are transforming pharma’s approach to commercial strategy. Ipsen’s Nicholas Phillips shares insights on leveraging AI for data-driven decision-making and improved patient outcomes.
Better brand planning with analytics teams and PCI
Enhancing Collaboration and Driving Better Outcomes
Successful brand planning is the product of great synergy between analytics and commercial teams. Patient-centric intelligence (PCI) has emerged as a game-changer, bridging the gap between these teams and enabling data-driven decision-making. Discover how PCI can enhance collaboration, improve brand performance, and ultimately drive better patient outcomes.
Download the Brand Planning Guide to Connect Care at the Core with Patient-centric Intelligence
Discover the power of patient-centric intelligence in our latest whitepaper, “Connect Care at the Core: A Brand Planning Guide.” This comprehensive resource explores how leveraging real-world insights can transform your brand planning process, uplifting market share and patient care.
Bridging the Gap: How Patient-centric Intelligence is Transforming Pharmaceutical Launches
Eric Chung, co-founder of Prospection, shares his experience on how patient-centric intelligence (PCI) can transform pharmaceutical launches. Learn how leveraging vast patient data and advanced techniques like machine learning can produce intelligence that optimises launch strategies, improves resource allocation, and ultimately enhances patient care.
Published Research: Otsuka sheds light on Myelodysplasia Treatment in Australia with Patient-centric Intelligence
A recent study in eJHaem led by Anoop Enjeti, MD, PhD, in collaboration with Otsuka and Prospection, highlights the importance of treatment adherence and the need for more treatment options for Myelodysplastic Syndromes (MDS). It also showcases the critical role patient-centric intelligence can play in deepening understanding of treatment performance and patient behaviors, on the path to improving patient outcomes.
Real-world study of the use of azacitidine in myelodysplasia in Australia
Uncovering real-world insights into MDS treatment in Australia: Our study in eJHaem highlights the importance of treatment adherence and the need for innovative solutions.
Published Research: How Johnson & Johnson Innovative Medicine Used Patient-centric Intelligence in Japan to Understand Care Advancements for Pulmonary Arterial Hypertension
A recent study by Johnson & Johnson Innovative Medicine Asia Pacific, in collaboration with Prospection, utilised patient-centric intelligence (PCI) in Japan to evaluate the persistence of endothelin receptor antagonists in pulmonary arterial hypertension (PAH) treatment.
Reimagining Brand Management With Patient-centric Intelligence
Patient-centric Intelligence (PCI) is transforming the way pharmas manage their brands. It helps companies quickly get to actionable insights informed by the patient journey, and insights centered around patients inevitably lead to better outcomes, for pharmas as well as patients.
Not all Data is Equal to the Task
Relying on sales data for market and patient insights delivers an incomplete picture of the patient journey, and missed opportunities arise as a result. You need a patient-centric analytics platform, giving you insights across brands and indications that transform patient care and commercial performance.
